JPRN-UMIN000000841已完成未知
Phase II study of second-line chemotherapy using modified FOLFOX6 in patients with advanced/ recurrent colorectal cancer (OGSG 0505) - OGSG 0505
OGSG0 个研究点目标入组 50 人开始时间: 2007年10月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •"1) Cavity fluid which needs drainage 2) with active double cancer except ca. in situ 3) with peripheral nerve disorder 4) with infectious disease which needs treatment 5) under watery diarrhea 6) with mental disorder which disturbs registration to this study 7) patients who receive steroids treatment 8) Cardiac failure, liver dysfunction, or renal dysfunction which disturb Registration to this study 9) pregnant women or women who like to be pregnant 10) history of severe allergy against drug 11) doctor's dicision not to be registered to this study"
研究者
相似试验
已完成
不适用
Phase II study of second-line chemotherapy using CPT-11 plus CDDP in patients with advanced/recurrent gastric cancer (OGSG 0504)Advanced/Recurrent gastric cancer which has no response to S-1JPRN-UMIN000000693Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)35
招募中
2 期
Phase II study of second line chemotherapy with carboplatin and paclitaxel for metastatic melanomamelanomaJPRN-UMIN000003260Division of Skin Oncology, Comprehensive cancer center, Saitama medical university International medical center40
已完成
2 期
Phase II study of Chemotherapy for Advanced or Recurrent ThymomaThymoma (excluding thymic carcinoma)JPRN-C000000350Japanese Association for Research on the Thymus50
已完成
2 期
A phase II study of combination chemotherapy with carboplatin plus S-1 in advanced lung squamous cell carcinomaung cancerJPRN-UMIN000006983Hamamatsu University School of Medicine50
已完成
2 期
A phase II study of combination chemotherapy with carboplatin plus S-1 in advanced and recurrence non small cell lung cancernon-small-cell lung cancerJPRN-UMIN000010189ational Hospital Organization Osaka20